Haojishi is an anti-inflammatory analgesic poultice that contains glycol salicylate and menthol as two of its main ingredients.
Available in China as a prescription medication, the product comes in two types; one that generates a hot sensation and another that creates a cool sensation.
The marketing rights for Haojishi are being transferred to Eisai‘s Chinese subsidiary Eisai China as the current contract between Teikoku Seiyaku and a local Chinese distributor is scheduled to expire at the end of December this year.
Teikoku Seiyaku will supply the finished product to Eisai China for distribution.